A neglected disease. Human sporotrichosis in a densely populated urban area in Sao Paulo, Brazil: clinical-epidemiological and therapeutic aspects

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
BITTENCOURT, Amanda Azevedo
OYAFUSO, Luiza Keiko Matsuka
CAVALIN, Roberta Figueiredo
PALHARES, Renata Bacic
XAVIER, Roseli Santos de Freitas
LOPES-BEZERRA, Leila M.
Citação
BRAZILIAN JOURNAL OF MICROBIOLOGY, v.53, n.2, p.739-748, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human sporotrichosis is caused by different Sporothrix species; however, Sporothrix brasiliensis is the main species, usually related to cat transmission in urban areas. A retrospective descriptive study was conducted at the Institute of Infectology Emilio Ribas from 2010 to 2018. Demography, clinical, diagnostic, and therapeutic data were obtained from medical records. Polymerase chain reaction of the calmodulin gene was performed to identify Sporothrix species. In addition, to evaluate the spread of the disease across Sao Paulo metropolitan region, TerraView version 4.2.2 software was used for geocoding cases according to residence addresses. Kernell's maps using QGIS software version 2.16.3 were constructed to determine the concentration of cases. Results: 260 cases of sporotrichosis were diagnosed between 2010 and 2018. We observed a 700% increment in the number of human cases in the 2016-2018 triennium compared with the 2013-2015 triennium. Female adults with a median age of 46 years old were the predominant infected group associated with cats' exposition at home care, although the age range of all patients was 01 to 86 years old. The main epidemiological risk of acquiring sporotrichosis was contact with cats, reported by 96.5% of the patients. Molecular identification showed that most of the tested isolates were Sporothrix brasiliensis. Lymphocutaneous form was observed in 59.2% and fixed cutaneous form in 37.5% of the patients. Regarding treatment, itraconazole was the main drug used (94.2%) with a cure rate of 98.8%. We observed an important spread of human sporotrichosis involving cat transmission caused by Sporothrix brasiliensis in a densely populated area of Sao Paulo state. These results are important to alert clinicians and dermatologists about the occurrence and progression of a neglected tropical disease in an urban area and the urgent necessity to include sporotrichosis as a differential diagnosis in the clinical investigation routine.
Palavras-chave
Human sporotrichosis, Urban area, Sporothrix brasiliensis, Cat transmission, Epidemiology
Referências
  1. Almeida-Paes R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003094
  2. Barros MBD, 2004, CLIN INFECT DIS, V38, P529, DOI 10.1086/381200
  3. Benvegnau AM, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0509-2019
  4. Brandolt TM, 2019, MED MYCOL, V57, P527, DOI 10.1093/mmy/myy082
  5. Castro RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075656
  6. Caus ALO, 2019, AM J TROP MED HYG, V100, P706, DOI 10.4269/ajtmh.18-0667
  7. Choappa RC, 2016, REV ARGENT MICROBIOL, V48, P196, DOI 10.1016/j.ram.2016.04.007
  8. de Beer ZW, 2016, STUD MYCOL, P165, DOI 10.1016/j.simyco.2016.07.001
  9. Eudes J, 2020, EMERG MICROBES INFEC, V9, P2515, DOI 10.1080/22221751.2020.1847001
  10. Fernandes GF, 2013, VIRULENCE, V4, P241, DOI 10.4161/viru.23112
  11. Gremiao IDF, 2020, EMERG INFECT DIS, V26, P621, DOI 10.3201/eid2603.190803
  12. Gremiao IDF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006077
  13. Gremiao IDF, 2021, BRAZ J MICROBIOL, V52, P107, DOI 10.1007/s42770-020-00365-3
  14. Grisoli JC, 2021, BRAZ J MICROBIOL, V52, P41, DOI 10.1007/s42770-020-00279-0
  15. Han HS, 2021, BRAZ J MICROBIOL, V52, P125, DOI 10.1007/s42770-020-00274-5
  16. Lecca LO, 2020, PREV VET MED, V176, DOI 10.1016/j.prevetmed.2020.104939
  17. Lopes-Bezerra LM, 2018, MED MYCOL, V56, pS126, DOI 10.1093/mmy/myx103
  18. Macedo-Sales PA, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1340-4
  19. Mahajan VK, 2014, DERMATOL RES PRACT, V2014, DOI 10.1155/2014/272376
  20. Marimon R, 2007, J CLIN MICROBIOL, V45, P3198, DOI 10.1128/JCM.00808-07
  21. Falcao EMM, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00109218, 10.1590/0102-311X00109218]
  22. Marques GF, 2015, AN BRAS DERMATOL, V90, P273, DOI 10.1590/abd1806-4841.20153447
  23. Marques Silvio Alencar, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P327, DOI 10.1590/S0036-46651993000400004
  24. Mialski R, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy081
  25. Montenegro H, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0269-5
  26. Orofino-Costa R, 2017, AN BRAS DERMATOL, V92, P606, DOI 10.1590/abd1806-4841.2017279
  27. Poester VR, 2018, ZOONOSES PUBLIC HLTH, V65, P815, DOI 10.1111/zph.12504
  28. Ramos-e-Silva M, 2007, CLIN DERMATOL, V25, P181, DOI 10.1016/j.clindermatol.2006.05.006
  29. Rodrigues AM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01385
  30. Cruz ILR, 2021, BRAZ J MICROBIOL, V52, P5, DOI 10.1007/s42770-020-00297-y
  31. Rossow JA, 2020, J FUNGI, V6, DOI 10.3390/jof6040247
  32. Schubach A, 2005, EMERG INFECT DIS, V11, P1952, DOI 10.3201/eid1112.040891
  33. Siew Han Hock, 2017, Med Mycol J, V58, pE107, DOI 10.3314/mmj.17.014
  34. Silva EA, 2015, B EPIDEMIOLOGICO PAU, V113, P1
  35. Silva-Vergara MLO, 2012, AM J TROP MED HYG, V86, P477, DOI 10.4269/ajtmh.2012.11-0441
  36. Tang MM, 2012, INT J DERMATOL, V51, P702, DOI 10.1111/j.1365-4632.2011.05229.x
  37. da Silva MBT, 2012, CAD SAUDE PUBLICA, V28, P1867, DOI 10.1590/S0102-311X2012001000006
  38. Veasey JV, 2021, AN BRAS DERMATOL, V96, P245, DOI 10.1016/j.abd.2020.07.010
  39. Zhang Y, 2015, PERSOONIA, V35, P1, DOI 10.3767/003158515X687416